In this article, we discuss the 10 best cancer stocks to buy now.
Keep Reading →
November 3 - Hedge Funds, News
In this article, we discuss the 10 best healthcare stocks to buy.
Keep Reading →
October 20 - Hedge Funds, News
In this article, we discuss the 10 best big pharma stocks to buy now.
Keep Reading →
October 8 - Hedge Fund Analysis, News
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Keep Reading →
October 4 - Hedge Funds, News
In this article we will take a look at the 15 most valuable biotech companies in the world.
Keep Reading →
July 30 - Hedge Funds, News
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Keep Reading →
June 21 - Hedge Funds, News
In this article we discuss the 5 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Keep Reading →
May 12 - Hedge Funds, News
Today we are going to take a look at the 10 easiest countries to adopt a child.
Keep Reading →
April 20 - Lists, News
In this article, we will take a look at the 15 best dividend stocks right now.
Keep Reading →
April 8 - Hedge Funds, News
In this article, we will discuss the 5 best dividend stocks right now.
Keep Reading →
April 8 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
March 22 - Hedge Funds, News
Distillate Capital, an employee-owned investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here.
Keep Reading →
January 27 - Hedge Fund Investor Letters, News
2020 was one of the worst years for dividend and dividend growth stocks as pandemic and economic meltdown have strongly impacted cash flow generation of dividend-paying companies...
Keep Reading →
January 23 - Dividend Stocks, Hedge Funds, News
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
December 14 - Hedge Funds, News
As Mr. Valuation, I find myself constantly reminding investors that value investing requires patience.
Keep Reading →
November 10 - Business, Dividend Stocks, Stock Analysis
In this article we are going to use hedge fund sentiment as a tool and determine whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now.
Keep Reading →
October 26 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
September 1 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 7 - Hedge Funds, News
In this article we will check out the progression of hedge fund sentiment towards Amgen, Inc. (NASDAQ:AMGN) and determine whether it is a good investment right now.
Keep Reading →
May 27 - Hedge Funds, News
We hate to say this but, we told you so.
Keep Reading →
April 24 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
Keep Reading →
March 11 - Hedge Funds, News
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Keep Reading →
December 25 - Hedge Funds, News
We can judge whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Keep Reading →
November 28 - Hedge Funds, News
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
October 9 - Hedge Funds, News
Ray Dalio, the billionaire founder of the world’s largest hedge fund, said there’s about a 25% chance of a U.S.
Keep Reading →
September 5 - Hedge Funds, Insider Trading
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Keep Reading →
June 6 - Hedge Funds, News
It's been a rather green day on Wall Street as all three major indexes are positive. The Dow Jones is up over 150 points while the S&P 500 is up 0.84%.
Keep Reading →
May 21 - News
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Keep Reading →
March 26 - Hedge Funds, News
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
December 8 - Hedge Funds, News
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital.
Keep Reading →
December 28 - Hedge Funds, News, Quantitative Investing
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Keep Reading →
July 17 - Dividend Stocks, News
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Keep Reading →
July 6 - News
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.
Keep Reading →
March 20 - News, Stock Analysis
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc.
Keep Reading →
March 17 - Market Movers, News
As a healthcare-focused fund, Michael Castor's Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered by the S&P 500 and the 8.3% drop...
Keep Reading →
March 3 - Hedge Fund Investor Letters, Hedge Funds, News
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.
Keep Reading →
February 9 - News, Stock Analysis
Etelcalcetide, an Amgen, Inc. (NASDAQ:AMGN) drug that is meant to treat secondary hyperparathyroidism has been approved by the U.S. Food and Drug Administration.
Keep Reading →
February 8 - News, Stock Analysis
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated to its own operations...
Keep Reading →
February 7 - News, Stock Analysis
What does 2017 hold for Amgen, Inc.
Keep Reading →
January 23 - News, Stock Analysis
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis
"Despite being one of the few prominent investors in the world to recognize the bubble brewing in the subprime mortgage markets and the crisis it would lead to when it burst, ...
Keep Reading →
November 30 - Hedge Funds
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Keep Reading →
November 23 - Hedge Funds, News
Third Avenue Management is a New York-based investment fund that uses a deep value investing strategy for stock selection.
Keep Reading →
October 29 - Hedge Fund Investor Letters, Hedge Funds, News
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September.
Keep Reading →
September 27 - Market Movers, News
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval from the FDA until ...
Keep Reading →
September 20 - News, Stock Analysis
Coherus Biosciences Inc (NASDAQ:CHRS) submitted a biologics licensing application (BLA) for its lead biosimilar development candidate earlier this month, and is drawing a lot ...
Keep Reading →
August 16 - News, Stock Analysis
Given that it's the middle of earnings season, it's not surprising that many major companies are trending today.
Keep Reading →
July 28 - Earnings Report, News